INCYTE CORPORATION Accrued Royalties, Current
INCYTE CORPORATION (INCY) had Accrued Royalties, Current of $37.45 million as of 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Notes › Accrued Liabilities, Current
us-gaap:AccruedRoyaltiesCurrent · last filed 2026-04-28
- 2026-03-31: Accrued Royalties, Current $37.45M.
- 2025-12-31: Accrued Royalties, Current $40.68M.
- 2025-09-30: Accrued Royalties, Current $36.94M.
- 2025-06-30: Accrued Royalties, Current $33.06M.
| Period end | Accrued Royalties, Current |
|---|---|
| 2026-03-31 | $37.45M 10-Q · filed 2026-04-28 |
| 2025-12-31 | $40.68M 10-Q · filed 2026-04-28 |
| 2025-09-30 | $36.94M 10-Q · filed 2025-10-28 |
| 2025-06-30 | $33.06M 10-Q · filed 2025-07-29 |
| 2025-03-31 | $549.25M 10-Q · filed 2025-04-29 |
| 2024-12-31 | $519.88M 10-K · filed 2026-02-10 |
| 2024-09-30 | $491.05M 10-Q · filed 2024-10-29 |
| 2024-06-30 | $444.31M 10-Q · filed 2024-07-30 |
| 2024-03-31 | $410.31M 10-Q · filed 2024-04-30 |
| 2023-12-31 | $387.36M 10-K · filed 2025-02-10 |
| 2023-09-30 | $354.95M 10-Q · filed 2023-10-31 |
| 2023-06-30 | $321.82M 10-Q · filed 2023-08-01 |
| 2023-03-31 | $286.23M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $263.47M 10-K · filed 2024-02-13 |
| 2022-09-30 | $248.46M 10-Q · filed 2022-11-01 |
| 2022-06-30 | $209.50M 10-Q · filed 2022-08-02 |
| 2022-03-31 | $171.96M 10-Q · filed 2022-05-03 |
| 2021-12-31 | $168.41M 10-K · filed 2023-02-07 |
| 2021-09-30 | $142.45M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $127.22M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $110.10M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $106.01M 10-K · filed 2022-02-08 |
| 2020-09-30 | $92.15M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $77.80M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $73.05M 10-Q · filed 2020-05-05 |
| 2019-12-31 | $73.22M 10-K · filed 2021-02-09 |
| 2019-09-30 | $52.86M 10-Q · filed 2019-10-29 |
| 2019-06-30 | $34.38M 10-Q · filed 2019-07-30 |
| 2019-03-31 | $20.08M 10-Q · filed 2019-04-30 |
| 2018-12-31 | $25.09M 10-K · filed 2020-02-13 |
| 2017-12-31 | $21.43M 10-K · filed 2019-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |